Showing 1 - 20 results of 3,889 for search '(((( n marked decrease ) OR ( second ((we decrease) OR (a decrease)) ))) OR ( a marker decrease ))', query time: 0.52s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

    Published 2025
    “…<p>(A) Bar graph showed EVO significantly decreased Lactate dehydrogenase (LDH) release in CER treated P<sub>i</sub>‐induced VSMCs. …”
  6. 6

    Repetitive stress induces a decrease in sound-evoked activity. by Ghattas Bisharat (20706928)

    Published 2025
    “…(f) A second group of mice followed the same procedures but without experiencing daily restraint stress (<i>N</i> = 3 mice, <i>n</i> = 123 neurons). …”
  7. 7
  8. 8
  9. 9
  10. 10

    Overview of the WeARTolerance program. by Ana Beato (20489933)

    Published 2024
    “…The quantitative results from Phase 1 demonstrated a decreasing trend in all primary outcomes. In phase 2, participants acknowledged the activities’ relevance, reported overall satisfaction with the program, and showed great enthusiasm and willingness to learn more. …”
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Raw images.pdf. by Longhai Li (4052044)

    Published 2025
    “…<div><p> Objective </p><p>Colorectal cancer (CRC) is the third most prevalent malignant tumor type and the second leading cause of cancer-related death. Sequence similarity family 50 member A (FAM50A) plays a vital role in numerous disease processes, including tumor progression. …”
  19. 19

    The primers related to FAM50A. by Longhai Li (4052044)

    Published 2025
    “…<div><p> Objective </p><p>Colorectal cancer (CRC) is the third most prevalent malignant tumor type and the second leading cause of cancer-related death. Sequence similarity family 50 member A (FAM50A) plays a vital role in numerous disease processes, including tumor progression. …”
  20. 20